These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 22372504)

  • 1. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling.
    Tao Q; Wu C; Xu R; Niu L; Qin J; Liu N; Zhang P; Wang C
    Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Wnt/β-catenin signaling pathway in cancer.
    Zhang Y; Wang X
    J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines.
    Zhang Y; Zhang X; Huang J; Dong Q
    Med Oncol; 2015 May; 32(5):157. PubMed ID: 25840791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment.
    Kim JY; Lee HY; Park KK; Choi YK; Nam JS; Hong IS
    Oncotarget; 2016 Apr; 7(15):20395-409. PubMed ID: 26967248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway.
    Wang Z; Wang N; Li W; Liu P; Chen Q; Situ H; Zhong S; Guo L; Lin Y; Shen J; Chen J
    Carcinogenesis; 2014 Oct; 35(10):2346-56. PubMed ID: 25085904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
    Zhang C; Zhang Z; Zhang S; Wang W; Hu P
    Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
    Hallett RM; Kondratyev MK; Giacomelli AO; Nixon AM; Girgis-Gabardo A; Ilieva D; Hassell JA
    PLoS One; 2012; 7(3):e33976. PubMed ID: 22470504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
    Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/beta-catenin pathway: modulating anticancer immune response.
    Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
    J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
    Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
    Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs.
    Jiang HL; Jiang LM; Han WD
    J BUON; 2015; 20(4):1094-100. PubMed ID: 26416062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway.
    Li X; Meng Y; Xie C; Zhu J; Wang X; Li Y; Geng S; Wu J; Zhong C; Li M
    J Cell Biochem; 2018 May; 119(5):4134-4141. PubMed ID: 29243835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
    Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.